Nanoreagents Against the Blood-Testis Barrier: A Strategy for Diagnosing and Treating Male Reproductive System Diseases

Male reproductive health represents a critical yet challenging area of medical science, where conventional diagnostics and therapies are often limited by physiological barriers-particularly the blood-testis barrier (BTB)-and the complex etiology of disorders such as infertility, prostate cancer, and erectile dysfunction. In recent years, nanoreagents has emerged as a transformative tool, enabling unprecedented advances in drug delivery, imaging, and therapeutic precision. This review systematically examines the application of diverse nanomaterials-including metal nanoparticles, lipid-based systems, polymeric carriers, and natural derivatives such as nanobodies, extracellular vesicles, and cell membrane-coated nanoparticles-in the context of male reproductive medicine. These platforms facilitate targeted drug delivery across the BTB, enhance local drug bioavailability, minimize systemic toxicity, and support sustained release profiles. In diagnostic imaging, nanotechnology augments modalities such as MRI, PET, and photoacoustic imaging. Furthermore, natural biomaterials offer biocompatible and immunologically inert strategies for drug encapsulation and targeted transport, improving both efficacy and safety. Despite these promising developments, challenges remain in standardization, long-term biosafety, and scalable synthesis. Nevertheless, the integration of nanotechnology in male reproductive health is poised to redefine treatment paradigms, offering personalized, efficient, and minimally invasive solutions. As research progresses, nano-based approaches hold significant potential to address unmet clinical needs and improve reproductive outcomes worldwide.